Delivery Order 75F40122D00006-75F40123F19003
Award Date
8/3/23
Potential Completion Date
8/2/25
Potential Value
$438K
Federal Agency
Food and Drug Administration
Awardee
Labstat International Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Labstat International Inc., a leading analytical testing laboratory, is for a stability study of cigarette tobacco filler on behalf of the Food and Drug Administration (FDA). The firm fixed price delivery order is valued at $112,994.60 and has a completion date of June 13, 2016. Labstat has been awarded multiple prior contracts from the FDA to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products in support...
This is a $1,215,324.40 Firm Fixed Price Delivery Order issued by the Food and Drug Administration (FDA) to Labstat International Inc., a leading analytical testing laboratory in Kitchener, Ontario. The contract is for Tobacco Lab Analysis Services and is part of a larger $45 million Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Labstat to provide laboratory services in support of the FDA's regulatory oversight of tobacco products. The contract covers a range of technical...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...
The Food and Drug Administration (FDA) has awarded a $802,650.92 firm-fixed-price delivery order contract to Labstat International Inc., a foreign-owned, for-profit analytical testing laboratory, to conduct chemical characterization of e-liquids and aerosols from electronic nicotine delivery systems (ENDS) containing non-tobacco nicotine. This work supports the FDA's regulatory oversight of tobacco products. The contract has an ultimate completion date of January 19, 2027 and was not set aside...
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Labstat International Inc., a for-profit limited liability company based in Canada. The $619,328.55 contract is for the chemical and physical characterization of pod and disposable e-cigarette aerosol. This order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract held by Labstat...
This is a $467,253.90 firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Labstat International Inc., a foreign-owned, for-profit organization. The contract is for the "Analysis of Matrix Specific HPHCS", which refers to the analysis of toxic constituents in tobacco, e-cigarette, cannabis, and CBD products to support the FDA's regulatory oversight. Labstat has been awarded multiple prior contracts by the...
The Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order contract worth $1,075,125.00 to Euromonitor International, Inc. to provide access to sales data and information reports on hookah, cigars, electronic nicotine delivery systems, smokeless tobacco, and cigarettes. This five-year contract, awarded without a set-aside, requires Euromonitor to deliver six customized reports annually from 2017 through 2024, plus one additional report per year covering emerging new tobacco...
This is a firm fixed-price delivery order issued by the Department of Health and Human Services Food and Drug Administration under the In Vivo Toxicology of Tobacco 2015-2020 indefinite delivery/indefinite quantity (IDIQ) contract. The $1,408,956.00 task order was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization, to perform detection and characterization of DNA adducts generated by tobacco flavorants in aerosol...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Battelle Memorial Institute, a nonprofit research and development organization, for a human pharmacokinetic and salivary pH study of large cigar smokers. The $919,786 contract supports the FDA's oversight and regulation of tobacco products. Battelle subcontracted with Virginia Commonwealth University to provide urinalysis services and Enthalpy Analytical, LLC to conduct testing of premium and little...
The U.S. Food and Drug Administration (FDA) awarded a $294,744.41 delivery order contract to Data Quality Science, LLC, a limited liability company based in Catonsville, Maryland. The contract is for tobacco retail inspections in FDA Region 4, which includes several western U.S. states and territories. This task order is part of a larger $35 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract the FDA awarded to Data Quality Science as a single-award, total small business set-aside....